Business, energy, technology, markets and global industry news from Business News Today

artificial intelligence

PharmaDeviceNews artificial intelligence
Representative image of an ultrasound exam in a modern imaging clinic, illustrating how Philips’ Elevate Plus FDA clearance could bring AI-enabled workflow support into routine diagnostic ultrasound.
Medical Devices & Diagnostics

How Philips’ Elevate Plus could change abdominal, breast and thyroid ultrasound workflows

Philips’ Elevate Plus puts AI inside ultrasound workflows. The real test is whether hospitals see faster scans and fewer repeat exams.

Read More
Representative image of AI-driven heart failure monitoring at home, showing how Coredio’s FDA breakthrough-designated platform could extend advanced cardiac assessment beyond hospital settings through wearables, blood pressure cuffs, and remote clinical review.
Medical Devices & Diagnostics

FDA breakthrough status gives Coredio’s AI heart failure platform a faster regulatory path

Coredio’s AI heart failure platform may bring hemodynamic insight into home care. See why FDA breakthrough status matters now.

Read More
Pharma & Biotech

Can AI help Biomunex find better bispecific antibody targets in cancer?

AI may speed cancer drug discovery, but Biomunex’s bigger test is whether smarter target pairing can translate into stronger immunotherapies.

Read More
Features & Analysis

Drug discovery has an AI problem. Clicklinks thinks the answer is connection, not just algorithms

Find out how Sanyou Bio’s Clicklinks platform could reshape AI-led drug discovery by linking biotech, CRO, CDMO and preclinical resources.

Read More
Pharma & Biotech

Can Anthropic’s Claude help Bristol Myers Squibb speed up medicine discovery and delivery?

Bristol Myers Squibb is moving AI from pilots to enterprise scale. Claude’s real test is governance, data trust and drug development impact.

Read More
Representative image: AI-powered digital pathology analysis could help reshape breast cancer risk stratification after ArteraAI Breast became the first FDA-cleared pathology-based breast cancer risk tool in the United States.
Medical Devices & Diagnostics

Can ArteraAI Breast turn routine pathology slides into breast cancer risk intelligence?

AI can read pathology slides, but can it change breast cancer treatment decisions? ArteraAI Breast puts that question before clinicians and payers.

Read More
Representative image of an AI-enabled autonomous biopharma lab, where robotic systems, automated assays and data-driven workflows are reshaping how researchers design experiments and accelerate drug discovery.
Features & Analysis

Are autonomous labs quietly turning biopharma researchers into scientific strategists?

Autonomous labs can run experiments faster. The bigger shift is what happens when biopharma researchers stop executing and start directing.

Read More
Medical Devices & Diagnostics Pharma & Biotech

Merck KGaA just made a quiet digital-health move. Could hybrid drugs be pharma’s next big reset?

Digital therapeutics struggled alone. Remepy and Merck KGaA are testing whether software works better when built into the drug itself.

Read More
Representative image of an AI-guided coronary imaging system in a modern cardiac catheterization lab, illustrating how Abbott’s Ultreon 3.0 clearance could push precision PCI, stent planning, and real-time artery analysis deeper into routine cardiovascular care.
Medical Devices & Diagnostics

Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease

AI can now guide coronary imaging in real time. Abbott’s Ultreon 3.0 puts precision PCI closer to routine clinical workflow.

Read More
Pharma & Biotech

From ARPA-H to Basilea: What Phare Bio’s new deal reveals about biotech partnerships

Phare Bio and Basilea partner to develop an AI-designed antibiotic for deadly gram-negative infections. Explore what this deal could mean for the future of antimicrobial R&D.

Read More